2265 North Clybourn Avenue    Chicago, IL 60614    P: 773.296.6700     F: 773.296.1131

Big Pharma, Bad Medicine

Posted 07/06/2010

Great title. Too bad it’s not my original, but this link will take you to the current issue of the Boston Review, and figuring we don’t see much of this magazine in Chicago, I’ll summarize its key points and hope (if you care a smidgen about your well-being) you’ll then read as much as you can endure without screaming.

The credentials of its authors are impeccable. Marcia Angell, MD, is the former editor-in-chief of the prestigious New England Journal of Medicine and current a senior lecturer at Harvard. Adrian Fugh-Berman, MD, is a professor of medicine at Georgetown University and directs PharmedOUT, which debates the collusion between medical education and Big Pharma. On the side of Big Pharma in the Boston Review debate, Emma D’Arcy is a so-called independent expert (who actually runs a PR firm with Big Pharma as her major client) on the relationship between academic medicine and Big Pharma. Dr. Angell dismisses Ms. D’Arcy as “being wrong on all fronts.” We’re not talking Reader’s Digest pleasantries here.

Here are some bullet points to whet your interest. Or to get enough information to challenge me, or any physician, who hands you a prescription for anything. Always bear in mind that Big Pharma is the single most profitable segment of our economy, and that although your prescription may seem financially “reasonable” with a ten or twenty dollar co-pay, the remaining $200 to $400 bill to your insurance company generates enormous profits for the Twelve Sisters of the industry (as well as dozens of new players).

• Big Pharma has an iron grip on academic medicine. Vast amounts of money are paid to medicals schools and medical school department chiefs to supply warm bodies for clinical studies of little value except to “prove” what the company wants them to prove. Generating results that please the company can mean millions of dollars in the coffers of everyone except you: the Big Pharma company, the medical school, and the pockets of “researchers.”

• Both the FDA and the NIH are compromised. Although ultimately the Food and Drug Administration (FDA) must give its stamp of approval before a new drug is released, virtually all the physician committee members have highly significant financial conflicts of interest with Big Pharma. And when the National Institutes of Health National Cholesterol Education Program decided to lower the LDL (bad cholesterol) number, which would determine when statin therapy should be initiated (thus putting millions of unsuspecting patients on statin drugs), virtually every physician involved in the NIH recommendation gained financially.

• Doctors are paid to “learn.” Like most professionals, physicians are expected to keep abreast of the latest developments in their field and accumulate CME (continuing medical education) credits. Although all other professionals, from beauticians to attorneys, pay for educational programs, doctors get theirs free, usually with food and sometimes even travel, via Big Pharma-sponsored “seminars” that are really subtle commercials for their products.

• Drug treatment for non-diseases. The subtlety of these seminars comes from the fact that although a specific drug may not be mentioned, diseases are literally created that can then be treated with the drug whose company is sponsoring the event. What these non-diseases have in common is this: they can usually be treated without drugs by making lifestyle changes and taking nutritional products. These non-diseases include high cholesterol, restless legs syndrome, social anxiety disorder, shift worker’s sleep disorder, and irritable bowel syndrome.

• Medical journals brought to you by…Big Pharma. The medical journals flooding a physician’s mailbox are virtually free to the physician and financially supported by Big Pharma. At one time, doctors flipped through pages of drug advertisements and the ads worked subliminally. These days, many journal articles themselves are ghostwritten by professional companies contracted by Big Pharma to massage data in order to make a new drug look good. The listed “physician authors” have signed off on the article (often without even reading it) for a juicy professional reviewing “stipend.”

• That will be $1,073 for 100 capsules. When they’re not creating new diseases to make money, Big Pharma is endlessly reconfiguring or changing the tablet strength of drugs about to go off-patent to generic (and far less expensive) status to avoid completely losing their cash cow. This allows them to extend their patent and keep the price high. Ambien (zolpidem) generic sells for $10.74 for 100 pills at Costco. Ambien CR (controlled release), a patent extender, sells for $599.18 per 100 pills (yes, over 50 times the generic price). Restoril (temazepam), another sleep aid, is generic in 15-mg and 30-mg tablets, selling for $24 per 100. The new Restoril 22.5-mg pill (“clinically proven most effective” says the drug rep handing me “studies from a major medical school to prove it”) sells for $1,073 per 100 caps (!).

• Generic doesn’t always mean inexpensive. Now the generic manufacturers themselves can smell the meat a-cookin’. They contract to be the “exclusive generic manufacturers” of a drug. When that drug goes off patent, the price stays the same or at best goes down a couple of percentage points.

I’m sure you’re getting the drift here. It’s essential that you the consumer see the other side of Big Pharma, the side behind every prescription–needed and not needed–your doctor writes.

I can’t believe the nerve of the TV drug commercials (banned worldwide except in the US and South Africa) shamelessly touting drugs in ways that make snake oil salesmen from the 19th century look like Albert Schweitzer. At least snake oil is high in anti-inflammatory essential fatty acids.

Next week: I get hypnotized by a pharmaceutical market research firm.

Leave a Comment


Join our Newsletter

Get health recommendations, delicious and time-saving recipes, medical news, supplement reviews, birthday discounts, and more!

BIRTHDAY

Health Tips

Dr. Edelberg’s Health Tips contain concise bits of advice, medical news, nutritional supplement and pharmaceutical updates, and stress relief ideas. With every Health Tip, you’ll also receive an easy, delicious, and healthful recipe.

When you sign up to receive Health Tips, you can look forward to Dr. Edelberg’s smart and very current observations arriving in your in-box weekly. They’re packed with helpful information and are often slightly irreverent. One of the most common responses to the tips is “I wish my doctor talked to me like this!”

Quick Connect

Get One Click Access to our

patient-portal

The Knowledge Base

Patient education is an integral part of our practice. Here you will find a comprehensive collection of staff articles, descriptions of therapies and nutritional supplements, information addressing your health concerns, and the latest research on nutritional supplements and alternative therapies.

Join our Newsletter

Get health recommendations, recipes, medical news, supplement reviews, birthday discounts, and more!

Upcoming Workshops

**Winter Solstice Celebration: Drumming Circle and Shamanic Healing
Wednesday, December 19, 2018, 5:45-7:30pm
Katie OberlinHTCP/I
Healing Touch Certified Practitioner/Instructor
Fee: $55.00

Take a break from the hustle and bustle of the holiday season to enter the stillpoint of the Winter Solstice, reflect on the lessons of 2018, and set intentions for the new year. This will be an evening of individual and group healing, ceremony, and celebration.

Space is limited and registration is required.
Please register online.
Call the Center for additional information at (773) 296-6700
More>>

Recent Health Tips

  • Making Sense of “Controversial” Diagnoses

    I’m warning you in advance. You’re entering a minefield here, with explosive views among seemingly conservative health care professionals. At least wear a helmet. Protective eyewear wouldn’t hurt either. You wouldn’t think a slew of conditions you’ve heard about (including chronic Lyme disease, chronic fatigue syndrome, fibromyalgia, chronic Epstein-Barr, toxic mold syndrome, food sensitivities, intestinal dysbiosis, chronic inflammatory response syndrome, and mast cell activation syndrome) Read More

  • Getting Tough With Your Immune System

    No reasonable physician (I modestly include myself here) can refrain from crowing delightedly when a clinical study confirms the value of a treatment he or she had been using for years, even if that treatment had contradicted prevailing standards. Ever since I learned something about natural medicine, I’ve been reluctant to prescribe antibiotics for respiratory tract infections, such as colds, sore throats, and bronchitis. Many physicians had Read More

  • For A Longer Life…Stand Up Now!

    By far the most common answer to my question, “Exercising these days?” is “Not enough.” This is usually accompanied by the briefest flicker of melancholy regret, as if by such a confession my patient has permanently abandoned the hopes and dreams of both a svelte body and enviable longevity. “Don’t worry,” I say, “It’s just a temporary glitch. You’ll start up again.” (Nod, nod). I Read More

December Sale: 20% Off the UltraLux IV Light Box

Full Spectrum Solutions has been an industry leader for the past 20 years, offering therapeutic lighting that is made right here in the Midwest (Michigan). The UltraLux IV is the first and only LED light therapy unit on the market that is both fully adjustable. Unlike many of their competitors, they boast a high CRI rating (90+) and a lifetime warranty so you never have to purchase replacement bulbs again. Full spectrum light therapy is often recommended in cases of Seasonal Affective Disorder (SAD) to help make up for the sunlight that is missing from these shorter, winter days.

To learn more about and purchase the UltraLux IV, click here.

To see past Health Tips on Seasonal Affective Disorder (SAD) and Dr. Edelberg’s recommendations, including a full spectrum light box like the UltraLux IV, click here.